ROCHE

📅 Upcoming

🕒 Recent(90d)

News

• Roche pours $750M into Oregon manufacturing plant as obesity push expands
  After committing $2 billion to a new North Carolina facility to boost capacity for its next-gen obesity candidates, Roche's Genentech is putting down more cash to expand a device fill-finish site i…
  biospace · 8h ago
• Kolon TissueGene cuts 37 US staffers after Phase 3 fail
  Follow along as BioSpace tracks job cuts and restructuring initiatives.
  biospace · 1d ago
• Novo takes first round of oral obesity duel. Can it stay ahead of Lilly?
  Despite coming away with an early victory over Eli Lilly in the oral obesity face-off, analysts don’t expect Novo Nordisk’s lead to last for very long.
  biospace · 1d ago
• Chutes & Ladders—Former Legend CEO lands at K2
  Just weeks after Legend Biotech announced the departure of its CEO, Ying Huang, K2 Therapeutics has announced that Wang will now lead the startup, which was founded in 2024 with a $50 million seed…
  fiercebiotech · 7d ago
• Vaderis hauls in $152M to test an AKT-targeting drug
  The startup is one of at least a few young companies zeroing in on the rare bleeding disorder, hereditary hemorrhagic telangiectasia, with a more precise AKT blocker.
  biopharma_dive · 9d ago
• IRBs have a problem. Can North Star’s nonprofit model save it?
  As institutional review boards face pressure from companies and ethicists, North Star Review Board offers a nonprofit model as more independent.
  stat · 9d ago
• Labcorp nabs FDA green light for BRAF melanoma diagnostic
  The FDA has signed off on Labcorp’s companion diagnostic for patients with advanced melanoma carrying certain BRAF variants.
  fiercebiotech · 10d ago
• FDA issues alert in wake of BD recall of faulty needle sets
  The FDA’s Center for Devices and Radiological Health issued an early alert for Becton Dickinson’s Intraosseous Vascular Access system needle sets in the wake of four deaths and 45 serious injuries…
  fiercebiotech · 10d ago
• Why Big Pharma is chasing the industry’s most-powerful supercomputer
  Bristol Myers Squibb is the latest major drugmaker to tap Nvidia for more computing power, betting that larger models and AI agents can speed drug discovery.
  biopharma_dive · 13d ago
• Roche adds cyclospora PCR tests as outbreak widens
  Roche is launching new tests for cyclospora as an outbreak linked to iceberg lettuce from Mexico continues to spread across U.S. states.
  fiercebiotech · 13d ago